Modification with polysialic acid–PEG copolymer as a new method for improving the therapeutic efficacy of proteins

Jianrong Wu, Shaozeng Lu, Z. Zheng, Li Zhu, X. Zhan
{"title":"Modification with polysialic acid–PEG copolymer as a new method for improving the therapeutic efficacy of proteins","authors":"Jianrong Wu, Shaozeng Lu, Z. Zheng, Li Zhu, X. Zhan","doi":"10.1080/10826068.2015.1135463","DOIUrl":null,"url":null,"abstract":"ABSTRACT A new protein derivatization method was developed with a block copolymer to reduce the immunogenicity of therapeutic proteins. The block copolymer consisted of polyethylene glycol (PEG) and polysialic acid (PSA), a nonimmunogenic and biodegradable biopolymer. Uricase was used as a model protein. Molecular weight analysis results indicated that the uricase–PEG–PSA conjugate was linked with 2.5 copolymers for each uricase unit. The residual enzyme activity of the uricase with modification by the PEG–PSA copolymer was 72.4%. The tolerance and stability to heat, acid, alkaline, and trypsin treatments significantly improved compared with the native uricase. The immunogenicity of uricase modified with PEG–PSA copolymer was remarkably reduced. The transmission electron microscopy results of the uricase–PEG–PSA conjugate showed a spherical hydrated shell with a larger particle size. These findings proved that the PSA–PEG–protein conjugate is a formulation that can potentially be used to deliver the protein and peptide-based drugs.","PeriodicalId":20393,"journal":{"name":"Preparative Biochemistry and Biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preparative Biochemistry and Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/10826068.2015.1135463","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

ABSTRACT A new protein derivatization method was developed with a block copolymer to reduce the immunogenicity of therapeutic proteins. The block copolymer consisted of polyethylene glycol (PEG) and polysialic acid (PSA), a nonimmunogenic and biodegradable biopolymer. Uricase was used as a model protein. Molecular weight analysis results indicated that the uricase–PEG–PSA conjugate was linked with 2.5 copolymers for each uricase unit. The residual enzyme activity of the uricase with modification by the PEG–PSA copolymer was 72.4%. The tolerance and stability to heat, acid, alkaline, and trypsin treatments significantly improved compared with the native uricase. The immunogenicity of uricase modified with PEG–PSA copolymer was remarkably reduced. The transmission electron microscopy results of the uricase–PEG–PSA conjugate showed a spherical hydrated shell with a larger particle size. These findings proved that the PSA–PEG–protein conjugate is a formulation that can potentially be used to deliver the protein and peptide-based drugs.
聚唾液酸-聚乙二醇共聚物修饰是提高蛋白质治疗效果的新方法
摘要:提出了一种利用嵌段共聚物进行蛋白质衍生化的新方法,以降低治疗蛋白的免疫原性。嵌段共聚物由聚乙二醇(PEG)和聚唾液酸(PSA)组成,这是一种非免疫原性和可生物降解的生物聚合物。以尿酸酶为模型蛋白。分子量分析结果表明,脲酶- peg - psa偶联物每个脲酶单元与2.5个共聚物相连。经PEG-PSA共聚物修饰后的尿酸酶残留酶活性为72.4%。与天然尿酸酶相比,该酶对热、酸、碱和胰蛋白酶的耐受性和稳定性显著提高。PEG-PSA共聚物修饰的尿酸酶免疫原性明显降低。尿素酶- peg - psa偶联物的透射电镜结果显示为球形水合壳,粒径较大。这些发现证明,psa - peg -蛋白缀合物是一种可以潜在地用于递送蛋白质和肽基药物的制剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信